Patient-Tailored Cancer Therapeutics - The Tempo Project

Sun, Apr 1, 2007·

Jean Clairambault

François Fages

Sylvain Soliman

· 0 min read

HAL

Abstract

‘Temporal Genomics for Tailored Chronotherapeutics’ (Tempo), is a European project partly funded by the European Union’s FP6-LifeSciHealth programme. The project investigates the possibility of individual cancer therapeutics by genetic profiling of cellular drug processing mechanisms and their circadian rhythms.

Type

Journal article

Publication

ERCIM News, 2007 (69):24-25

Last updated on Sun, Apr 1, 2007

← Proceedings of CSCLP 2007: Annual ERCIM Workshop on Constraint Solving and Constraint Logic Programming Sat, Dec 1, 2007

Coupling the Cell cycle and the Circadian Cycle Fri, Dec 1, 2006 →